MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR AND TRANSARTERIAL EMBOLIZATION FOR TREATMENT OF TUBEROUS SCLEROSIS COMPLEX PATIENTS WITH RENAL ANGIOMYOLIPOMA Article Hsiao W.C., Wang S.C., Chen S.L., Tsai J.D. Urological Science. Vol. 29. 2018. P. 100-105
FACTORS OF ADHERENCE TO TREATMENT WITH TROSPIUM IN EMPLOYEES Article Kosilov K.V., Kuzina I.G., Shakirova O.V., Zhuravskaya N.S., Loparev S.A., Lobodenko A. Urological Science. Vol. 28. 2017. P. 139-146